What should be considered on design of a colon-specific prodrug?
about
Nanomedicine in GICelecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.Colon-targeted delivery of piceatannol enhances anti-colitic effects of the natural product: potential molecular mechanisms for therapeutic enhancementEvaluation of glycine-bearing celecoxib derivatives as a colon-specific mutual prodrug acting on nuclear factor-κB, an anti-inflammatory target.Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.Dextran-5-(4-ethoxycarbonylphenylazo)salicylic acid ester, a polymeric colon-specific prodrug releasing 5-aminosalicylic acid and benzocaine, ameliorates TNBS-induced rat colitis.Susceptibility of glucocorticoids to colonic metabolism and pharmacologic intervention in the metabolism: implication for therapeutic activity of colon-specific glucocorticoid 21-sulfate sodium at the target site.Structural effects of N-aromatic acyl-amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon-specific prodrug with controlled conversion rate at the target site.Colonic delivery of celecoxib is a potential pharmaceutical strategy for repositioning the selective COX-2 inhibitor as an anti-colitic agent.Colon-specific delivery of celecoxib is a potential strategy to improve toxicological and pharmacological properties of the selective Cox-2 inhibitor: implication in treatment of familiar adenomatous polyposis.Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole.
P2860
Q34719056-62E34E52-4C68-4FCA-B7C0-5646B4F92124Q35915162-AC4508F5-D83F-45D9-8156-4B726A3C5BF3Q35939442-CEF28645-A154-4A93-A25B-B6AA560513DEQ35950544-14DD78E6-D8A4-4ECF-9458-230513A44CB4Q37652864-297EEA84-8B4D-47AD-A2E2-189CBA481CCBQ40532305-307B73C7-1CCC-44D9-A7AF-84A196FB5C3EQ45170592-6BDE19A2-2EDC-4FF0-B054-715E1B411644Q46346584-8CC016CF-7CDF-4BAF-8836-83617B65A525Q50990866-F709B429-BF87-472B-8AD3-A71E24B60C4EQ54335757-865D6AAC-3896-4610-A9FA-0110F2DB5C96Q54347952-FB9AEDFF-21EB-4B38-961C-9D19986A9765
P2860
What should be considered on design of a colon-specific prodrug?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
What should be considered on design of a colon-specific prodrug?
@en
What should be considered on design of a colon-specific prodrug?
@nl
type
label
What should be considered on design of a colon-specific prodrug?
@en
What should be considered on design of a colon-specific prodrug?
@nl
prefLabel
What should be considered on design of a colon-specific prodrug?
@en
What should be considered on design of a colon-specific prodrug?
@nl
P2860
P1476
What should be considered on design of a colon-specific prodrug?
@en
P2093
Young Mi Kim
Yunjin Jung
P2860
P304
P356
10.1517/17425240903490401
P407
P577
2010-02-01T00:00:00Z